References

  1. Martin BR, et al. J Support Oncol. 2004;2(4):305-316.

  2. Di Marzo V, et al. Nature. 2001;410:822-825.

  3. Darmani NA, et al. Pharmacol Biochem Behav. 2003;75:777-787.

  4. Schlicker E, et al. Trends Pharmacol Sci. 2001;22(11):565-572.

  5. MARINOL [package insert]. Marietta, GA: Unimed Pharmaceuticals, Inc., a Solvay Pharmaceuticals, Inc. company; 2006.

  6. Beal JE, et al. J Pain Symptom Manage. 1995;10(2):89-97.

  7. Joy JE, et al, eds. Cannabinoids and animal physiology. In: Marijuana and Medicine: Assessing the Science Base. Washington, DC: National Academy Press; 1999:33-81.

  8. Cota D, et al. Int J Obesity. 2003;27:289-301.

  9. Lupica CR, et al. Br J Pharmacol. 2004;143:227-234.

  10. Wiley JL, et al. Br J Pharmacol. 2005;145:293-300.

  11. Howlett AC, et al. Pharmacol Rev. 2002;54:161-202.

  12. Beal JE, et al. J Pain Symptom Manage. 1997;14(1):7-14.

  13. Kosel BW, et al. AIDS. 2002;16:543-550.

  14. Kim JH, et al. Am J Clin Nutr. 2001;74:852-861.

  15. Macallan DC, et al. N Engl J Med. 1995;333:83-88.
Next: — MARINOL and Oncology
Links Contact Prescribing Information Subscribe to Email Alerts Home

Solvay

© 2006 Solvay Pharmaceuticals, Inc.
Please read our Legal Notices and our Privacy Policy.
Product information provided on this site is intended for US residents only. This information is made available to the public for educational purposes only. It should not be used for diagnosing a health problem or disease. It is not meant to be a substitute for the advice of a physician or other health care provider.